Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 11, Issue 8
Oncolytic viruses and antibodies: are they more successful when delivered separately or when engineered as a single agent?
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Review
Oncolytic viruses and antibodies: are they more successful when delivered separately or when engineered as a single agent?
Online download statistics by month:
Online download statistics by month: August 2023 to August 2024
Abstract
Full
Pdf
Aug 2023
570
577
207
Sep 2023
223
226
57
Oct 2023
135
151
60
Nov 2023
200
208
48
Dec 2023
172
174
73
Jan 2024
57
59
28
Feb 2024
68
69
25
Mar 2024
112
114
51
Apr 2024
110
110
40
May 2024
267
269
42
Jun 2024
65
67
32
Jul 2024
104
107
43
Aug 2024
70
69
23
Total
2153
2200
729
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF